CR Shuanghe: Innovation Business Unit has established an AI team to provide appropriate support for overall drug discovery
36 Krypton was informed that China Resources Shuanghe said on the interactive platform that the core of the company's new drug development is mainly compound screening in the front section, and the use of AI intelligence for compound screening through the design of the target can quickly find the lead compound. The company's Innovation Division has established an AI team to provide appropriate support for overall drug discovery, while actively working with the State Key Laboratory and relevant organizations in Beijing for joint cooperation and development to provide appropriate cooperation opportunities for the company's new drug development and compound screening.
36氪获悉，华润双鹤在互动平台表示，公司新药研发的核心在前段主要是化合物筛选，通过靶点的设计利用AI智能进行化合物筛选，能够快速找到先导化合物。公司创新事业部建立了AI团队，对整体的药物发现提供相应支持，同时积极和国家重点实验室以及北京市相关机构进行联合合作和开发，为公司新药的研发和化合物筛选提供相应的合作机会。
Add comment
Comments